Development and Validation of a Clinical Score for Predicting High Tuberculosis Risk in Chinese Psoriasis Patients Prior to Biologic Therapy
A multicenter Chinese study developed and externally validated the Psoriasis TB Risk Score (PTRS) to stratify psoriasis patients' risk of high interferon-γ release assay (IGRA) responses before biologic treatment, facilitating tailored TB screening in high-burden settings.